UnitedHealth Group Incorporated (NYSE:UNH) Stake Lessened by Sheets Smith Wealth Management

Sheets Smith Wealth Management decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 4,936 shares of the healthcare conglomerate’s stock after selling 458 shares during the quarter. Sheets Smith Wealth Management’s holdings in UnitedHealth Group were worth $2,497,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of UNH. Resources Management Corp CT ADV increased its holdings in shares of UnitedHealth Group by 4.2% in the 2nd quarter. Resources Management Corp CT ADV now owns 13,839 shares of the healthcare conglomerate’s stock worth $7,048,000 after acquiring an additional 563 shares during the period. Manchester Global Management UK Ltd boosted its position in shares of UnitedHealth Group by 12.7% during the second quarter. Manchester Global Management UK Ltd now owns 154,918 shares of the healthcare conglomerate’s stock worth $78,894,000 after buying an additional 17,500 shares during the period. Mill Creek Capital Advisors LLC raised its stake in UnitedHealth Group by 20.1% during the 2nd quarter. Mill Creek Capital Advisors LLC now owns 1,983 shares of the healthcare conglomerate’s stock valued at $1,010,000 after acquiring an additional 332 shares in the last quarter. Distillate Capital Partners LLC increased its holdings in shares of UnitedHealth Group by 563,752.2% during the second quarter. Distillate Capital Partners LLC now owns 129,686 shares of the healthcare conglomerate’s stock valued at $66,044,000 after purchasing an additional 129,663 shares during the period. Finally, Strata Wealth Advisors LLC acquired a new stake in shares of UnitedHealth Group in the 2nd quarter worth approximately $453,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $524.78 on Wednesday. The business has a fifty day simple moving average of $547.07 and a 200 day simple moving average of $563.84. The company has a market cap of $482.95 billion, a P/E ratio of 33.86, a P/E/G ratio of 1.38 and a beta of 0.62. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter last year, the firm earned $5.83 EPS. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.77 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.60%. UnitedHealth Group’s payout ratio is presently 54.19%.

Analyst Ratings Changes

A number of research firms have recently issued reports on UNH. Piper Sandler cut their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Barclays dropped their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Stephens raised their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Finally, KeyCorp reaffirmed an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Two research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.